method for modulating hepatitis b cccdna transcription in an individual, method for modulating covalently closed circular hepatitis b virus dna and compound
BARUCH S. BLUMBERG INSTITUTE;BARUCH S. BLUMBERG INSTITUTE;DREXEL UNIVERSITY;DREXEL UNIVERSITY
发明人:
HAROLD R. ALMOND,HAROLD R. ALMOND,JINHONG CHANG,JINHONG CHANG,JU-TAO GUO,JU-TAO GUO,TIMOTHY M. BLOCK,TIMOTHY M. BLOCK,WILLIAM A. KINNEY,WILLIAM A. KINNEY
申请号:
BR112014029697
公开号:
BR112014029697A2
申请日:
2013.05.31
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
The present invention provides small molecule inhibitors of hepatitis B virus (HBV) covalently closed circular (ccc) DNA, which are useful as therapeutics in the management of chronic HBV. The compounds of the invention achieve epigenetic modification of the cccDNA, histone modification and histone deacetylase activity inhibition, thus modulating HBV cccDNA. The present invention further provides methods for modulating HBV cccDNA, for treating or preventing HBV in a subject, and for modulating cccDNA transcription of hepatitis B in a subject.